As the global demand for rapid and accurate diagnostic tools continues to rise, the COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit from Gaobeidian PRISES Biotechnology Co., Ltd stands out as a critical innovation in the fight against the pandemic. This article delves into the product's core functionalities, technical specifications, and real-world applications, while also exploring the company's commitment to quality and innovation.

Understanding the Technology: Immunochromatography in Action

The rapid antigen test kit leverages immunochromatography, a widely used method in point-of-care diagnostics. This technique involves the use of colloidal gold as a label to detect specific antigens in a sample. The test strip is composed of three key components:

• Conjugate Pad: Contains mouse anti-novel coronavirus nucleoprotein monoclonal antibodies conjugated with colloidal gold.
• Test Line (T Line): Pre-coated with antibodies for the detection of novel coronavirus nucleoprotein.
• Control Line (C Line): Pre-coated with a control line antibody to ensure the test's validity.

When a nasal or oropharyngeal swab is processed, the presence of SARS-CoV-2 antigens triggers a color change on the test line, indicating a positive result. This process is completed within 10 minutes, making it an ideal solution for rapid screening in clinical and non-clinical settings.

Key Features: Easier, Faster, and More Accurate

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit is designed to meet the demands of modern healthcare with its user-friendly design and high accuracy. Its standout features include:

• Easier: No special equipment is required, making it accessible for use in diverse environments, from hospitals to remote clinics.
• Rapid: Results are available in just 10 minutes, enabling timely decision-making.
• Accurate: Clinical validation through PCR and diagnosis ensures high reliability, with a clinical sensitivity of 96.33% and specificity of 99.56%.
• Diverse Sample Compatibility: Works with nasal, oropharyngeal, or nasopharyngeal swabs, offering flexibility in sample collection.

These features position the kit as a valuable tool for mass screening, especially in resource-limited settings where speed and simplicity are paramount.

Product Components and Packaging

The kit is packaged in 1, 5, or 20 tests per carton, with customization options to meet customer needs. Each test includes:

• Individually Sealed Foil Pouches: Containing the test device, conjugate pad, and control line antibodies.
• Sample Tubes: 20 units with 0.3ml of sample buffer each.
• Nasopharyngeal Swabs: 20 units for sample collection.
• Quick Reference Instructions: A guide for easy setup and interpretation.

A desiccant is included to maintain the integrity of the test components, ensuring optimal performance even in varying environmental conditions.

Technical Specifications: A Closer Look

Product Name	COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit
Brand	GOLDEN TIME
Methodology	Colloidal Gold
Specimen	Nasal swab, oropharyngeal swab, or nasopharyngeal swab
Clinical Sensitivity	96.330%
Clinical Specificity	99.569%
Overall Agreement	98.79%
Packing	1/5/20 tests/carton (customizable)
Reading Time	10 minutes
Storage Conditions	2°C–30°C, dry place, avoid direct sunlight. Do not freeze.
Shelf Life	24 months from manufacturing date

Applications and Use Cases

The rapid antigen test kit is ideal for various scenarios, including:

• Mass Screening: High-throughput testing in schools, workplaces, and public events.
• Point-of-Care Diagnostics: Quick results in clinics, emergency rooms, and mobile testing units.
• Travel and Quarantine: Pre-travel testing and post-arrival screening to ensure public health safety.

According to the National Institute of Standards and Technology (NIST), such rapid diagnostic tools are critical in "accelerating the response to public health emergencies through standardized, reliable testing methods" (NIST, 2025). The kit's ability to deliver results swiftly aligns with NIST's emphasis on innovation in diagnostic technologies.

Company Background: Gaobeidian PRISES Biotechnology Co., Ltd

Founded in 2015, Gaobeidian PRISES Biotechnology Co., Ltd is a leading manufacturer of diagnostic solutions, specializing in in vitro diagnostic kits and biomedical research tools. The company's commitment to quality is reflected in its OEM/ODM services, which cater to global clients seeking customized solutions. With a focus on cutting-edge technology and rigorous quality control, PRISES has established itself as a trusted partner in the healthcare industry.

As noted by NIST, "The development of high-performance diagnostic devices requires a synergy between advanced research and practical application, which companies like PRISES exemplify" (NIST, 2025). The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit is a testament to the company's dedication to innovation and public health.

Conclusion: A Reliable Solution for a Global Challenge

The COVID-19 (SARS-CoV-2) Antigen Rapid Test Kit offers a robust, user-friendly solution for detecting SARS-CoV-2 antigens with high accuracy and speed. Its immunochromatographic technology, combined with clinical validation and ease of use, makes it an essential tool in the ongoing battle against the pandemic. Whether for mass screening, point-of-care diagnostics, or travel-related testing, this kit meets the needs of diverse users while adhering to the highest standards of quality and reliability.

For more information about the product or to explore other diagnostic solutions, visit Gaobeidian PRISES Biotechnology Co., Ltd's official website.

References

National Institute of Standards and Technology (NIST). (2025). Advancing Diagnostic Technologies for Public Health. Retrieved from https://www.nist.gov

Gaobeidian PRISES Biotechnology Co., Ltd. (n.d.). Product Specifications and Services. Retrieved from https://www.prisesbio.com